- Report
- October 2022
- 218 Pages
Global
From €3205EUR$3,600USD£2,800GBP
- Report
- August 2022
- 327 Pages
Global
From €3205EUR$3,600USD£2,800GBP
- Report
- January 2024
- 230 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- August 2023
- 180 Pages
Global
From €3338EUR$3,750USD£2,917GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 545 Pages
Global
From €3561EUR$4,000USD£3,111GBP
- Report
- November 2021
- 270 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- November 2021
- 802 Pages
Global
From €4451EUR$5,000USD£3,889GBP
- Report
- November 2021
- 1184 Pages
Global
From €5341EUR$6,000USD£4,667GBP
- Report
- November 2021
- 1165 Pages
Global
From €5341EUR$6,000USD£4,667GBP
€2531EUR$3,046USD£2,289GBP
- Book
- January 2025
Global
- Book
- August 2024
Global

The Transcriptome market is a subset of the biotechnology industry that focuses on the study of the transcriptome, which is the set of all RNA molecules in a cell. This includes messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules. Transcriptome analysis is used to study gene expression, gene regulation, and other aspects of gene function. It is also used to identify novel genes and to study the effects of genetic mutations.
The Transcriptome market is driven by the need for better understanding of gene expression and regulation, as well as the development of new treatments for diseases. Companies in this market are developing technologies and products to enable researchers to better understand the transcriptome and its role in health and disease.
Some companies in the Transcriptome market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and Qiagen. Show Less Read more